Bibliometric Analysis on Clinical Application of Bozhi Glycopeptides
- VernacularTitle:薄芝糖肽临床应用中文文献分析
- Author:
Siyang WANG
;
Qing LI
- Publication Type:Journal Article
- Keywords:
Bozhi glycopeptides;
Clinical application;
Adverse drug reaction;
Bibliometric analysis
- From:
China Pharmacist
2016;19(6):1174-1179
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinical application of Bozhi glycopeptides to provide reference for its rational use in clinics . Methods:The related literatures of Bozhi glycopeptides from the databases of CNKI , Wanfang and VIP were retrieved .The main clinical application ( the number of literatures on the same disease entities was above 3) and ADR were analyzed and evaluated .Results:A total of 163 literatures were found, including 137 clinical application and 11 ADR case reports.The disease with the number of literatures a-bove 3 included condyloma acuminatum (9 literatures), herpes zoster (6 literatures), hand-foot-mouth disease (6 literatures), psoriasis vulgaris (6 literatures), lung cancer (5 literatures), repeated respiratory infection (4 literatures) and hepatitis B (9 literatures), and the total number was 45.Among them, 32 literatures (1 772 cases) involved ADR, and 49 cases (2.77%) of ADR were reported, and the main performance was skin and its appendages damage (10 cases, 20.0%).Totally 11 ADR case reports mainly involved rigors and fever (13 cases, 37.2%).Conclusion:Bozhi glycopeptides as an adjuvant drug is mainly combined with other drugs to enhance the effi -cacy of mian drugs in clinical application , which shows low incidence of ADR mainly including skin and its appendages damage .
